glp-1 bowel obstruction law office in michigan gastric stasis lawyer Glucagon-like peptide-1 receptor agonists and muscle mass effects Mounjaro Lawsuit Update May 2026

In one of these studies, Daniel Woronow, MD, and colleagues from the FDA in Silver Spring, Maryland found that 36 patients taking semaglutide between 2005 and 2016 developed acute gallbladder disease, three of whom died

If thats the case, Fishman says you could talk to your healthcare provider about taking just the phentermine without the topiramate, which will help with the brain fog

See if youre eligible for Virta Health here

Book Your Consultation Now Both medications can be effective tools in a structured, medically supervised weight loss plan

FDA has approved Foundayo (orforglipron), developed by Eli Lilly and Company, as the first oral non-peptide GLP-1 receptor agonist for chronic weight management

The hormone then does several things simultaneously: it tells your pancreas to release insulin (berberine vs metformin), suppresses glucagon (which raises blood sugar), slows gastric emptying so you feel full longer, and signals satiety to your brain